184 related articles for article (PubMed ID: 32037222)
1. Protective efficacy of recombinant bacterin vaccine against botulism in cattle.
Moreira C; Ferreira MRA; Finger PF; Magalhães CG; Cunha CEP; Rodrigues RR; Otaka DY; Galvão CC; Salvarani FM; Moreira ÂN; Conceição FR
Vaccine; 2020 Mar; 38(11):2519-2526. PubMed ID: 32037222
[TBL] [Abstract][Full Text] [Related]
2. Protective potential of recombinant non-purified botulinum neurotoxin serotypes C and D.
Moreira C; da Cunha CE; Moreira GM; Mendonça M; Salvarani FM; Moreira ÂN; Conceição FR
Anaerobe; 2016 Aug; 40():58-62. PubMed ID: 27236078
[TBL] [Abstract][Full Text] [Related]
3. Vaccination of cattle with a recombinant bivalent toxoid against botulism serotypes C and D.
Cunha CE; Moreira GM; Salvarani FM; Neves MS; Lobato FC; Dellagostin OA; Conceição FR
Vaccine; 2014 Jan; 32(2):214-6. PubMed ID: 24252701
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of a Bivalent Non-Purified Recombinant Vaccine against Botulism in Cattle.
Moreira C; Ferreira MRA; da Cunha CEP; Donassolo RA; Finger PF; Moreira GMSG; Otaka DY; de Sousa LA; Barbosa JD; Moreira ÂN; Salvarani FM; Conceição FR
Toxins (Basel); 2018 Sep; 10(10):. PubMed ID: 30241350
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of long-term immune response in cattle to botulism using a recombinant E. coli bacterin formulated with Montanide™ ISA 50 and aluminum hydroxide adjuvants.
Moreira C; Rodrigues RR; da Cunha CEP; Donassolo RA; Ferreira MRA; Finger PF; Oliveira HGS; da Cruz KP; Moreira ÂN; Salvarani FM; Conceição FR
Microb Pathog; 2024 Apr; 189():106596. PubMed ID: 38395317
[TBL] [Abstract][Full Text] [Related]
6. Production and evaluation of a recombinant chimeric vaccine against clostridium botulinum neurotoxin types C and D.
Gil LA; da Cunha CE; Moreira GM; Salvarani FM; Assis RA; Lobato FC; Mendonça M; Dellagostin OA; Conceição FR
PLoS One; 2013; 8(7):e69692. PubMed ID: 23936080
[TBL] [Abstract][Full Text] [Related]
7. Humoral Response of Buffaloes to a Recombinant Vaccine against Botulism Serotypes C and D.
Otaka DY; Barbosa JD; Moreira C; Ferreira MRA; Cunha CEP; Brito ARS; Donassolo RA; Moreira ÂN; Conceição FR; Salvarani FM
Toxins (Basel); 2017 Sep; 9(10):. PubMed ID: 28937601
[TBL] [Abstract][Full Text] [Related]
8. Recombinant vaccine against botulism in buffaloes: Evaluation of the humoral immune response over 12 months.
Otaka DY; Barbosa JD; de Souza LA; Moreira C; Ferreira MRA; Donassolo RA; Conceição FR; Salvarani FM
Anaerobe; 2020 Jun; 63():102201. PubMed ID: 32247696
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Clostridium botulinum types C and D toxoid vaccination in Danish cows.
Krüger M; Skau M; Shehata AA; Schrödl W
Anaerobe; 2013 Oct; 23():97-101. PubMed ID: 23831724
[TBL] [Abstract][Full Text] [Related]
10. Enhancing toxin-based vaccines against botulism.
Przedpelski A; Tepp WH; Zuverink M; Johnson EA; Pellet S; Barbieri JT
Vaccine; 2018 Feb; 36(6):827-832. PubMed ID: 29307477
[TBL] [Abstract][Full Text] [Related]
11. Production of recombinant botulism antigens: a review of expression systems.
Moreira GM; Cunha CE; Salvarani FM; Gonçalves LA; Pires PS; Conceição FR; Lobato FC
Anaerobe; 2014 Aug; 28():130-6. PubMed ID: 24930432
[TBL] [Abstract][Full Text] [Related]
12. Alternative vaccination against equine botulism (BoNT/C).
Frey J; Eberle S; Stahl C; Mazuet C; Popoff M; Schatzmann E; Gerber V; Dungu B; Straub R
Equine Vet J; 2007 Nov; 39(6):516-20. PubMed ID: 18065309
[TBL] [Abstract][Full Text] [Related]
13. Development and evaluation of candidate subunit vaccine and novel antitoxin against botulinum neurotoxin serotype E.
Shi DY; Liu FJ; Mao YY; Cui RT; Lu JS; Yu YZ; Dong XJ; Yang ZX; Sun ZW; Pang XB
Hum Vaccin Immunother; 2020; 16(1):100-108. PubMed ID: 31210561
[TBL] [Abstract][Full Text] [Related]
14. Development and evaluation of candidate subunit vaccine against botulinum neurotoxin serotype B.
Shi DY; Chen BY; Mao YY; Zhou G; Lu JS; Yu YZ; Zhou XW; Sun ZW
Hum Vaccin Immunother; 2019; 15(3):755-760. PubMed ID: 30433836
[TBL] [Abstract][Full Text] [Related]
15. Recombinant Botulinum Neurotoxin Hc Subunit (BoNT Hc) and Catalytically Inactive Clostridium botulinum Holoproteins (ciBoNT HPs) as Vaccine Candidates for the Prevention of Botulism.
Webb RP; Smith TJ; Smith LA; Wright PM; Guernieri RL; Brown JL; Skerry JC
Toxins (Basel); 2017 Sep; 9(9):. PubMed ID: 28869522
[TBL] [Abstract][Full Text] [Related]
16. Safety and immunogenicity of investigational recombinant botulinum vaccine, rBV A/B, in volunteers with pre-existing botulinum toxoid immunity.
Khouri JM; Motter RN; Arnon SS
Vaccine; 2018 Apr; 36(15):2041-2048. PubMed ID: 29475762
[TBL] [Abstract][Full Text] [Related]
17. Cattle immune response to botulinum type D toxoid: results of a vaccination study.
Steinman A; Galon N; Arazi A; Bar-Giora Y; Shpigel NY
Vaccine; 2007 Nov; 25(44):7636-40. PubMed ID: 17913314
[TBL] [Abstract][Full Text] [Related]
18. Immune response of horses to vaccination with the recombinant Hc domain of botulinum neurotoxin types C and D.
Stahl C; Unger L; Mazuet C; Popoff M; Straub R; Frey J
Vaccine; 2009 Sep; 27(41):5661-6. PubMed ID: 19646409
[TBL] [Abstract][Full Text] [Related]
19. Production and evaluation of a recombinant subunit vaccine against botulinum neurotoxin serotype B using a 293E expression system.
Yu Y; Shi D; Liu S; Gong ZW; Wang S; Sun Z
Hum Vaccin Immunother; 2015; 11(2):468-73. PubMed ID: 25483668
[TBL] [Abstract][Full Text] [Related]
20. Chronic botulism in a Saxony dairy farm: sources, predisposing factors, development of the disease and treatment possibilities.
Krüger M; Neuhaus J; Herrenthey AG; Gökce MM; Schrödl W; Shehata AA
Anaerobe; 2014 Aug; 28():220-5. PubMed ID: 24997242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
